Skip to content
10-Q

Quarterly Report

CHECKPOINT THERAPEUTICS, INC.

0001410578-24-001317

← back to feed
Filed
Aug 12, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2024 · Jun 30, 2024 36.53M sh
Shares Diluted Q2 2024 · Jun 30, 2024 34.73M sh
Shares Diluted Q2 2024 · Jun 30, 2023 15.7M sh
Shares Diluted Q2 2024 · Jun 30, 2023 13.74M sh
Shares Outstanding Q2 2024 · Jun 30, 2024 41.63M sh
Shares Outstanding Q2 2024 · Dec 31, 2023 27.04M sh
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$12.71M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$26.01M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $4.95M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $4.93M
Stockholders Equity Q2 2024 · Jun 30, 2024 −$15.75M
Stockholders Equity Q2 2024 · Mar 31, 2024 −$10.25M
Stockholders Equity Q2 2024 · Dec 31, 2023 −$13.05M
Stockholders Equity Q2 2024 · Jun 30, 2023 −$23.27M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$22.18M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$19.48M
Current Liabilities Q2 2024 · Jun 30, 2024 $21.42M
Current Liabilities Q2 2024 · Dec 31, 2023 $18.43M
Total Liabilities Q2 2024 · Jun 30, 2024 $21.42M
Total Liabilities Q2 2024 · Dec 31, 2023 $18.43M
Current Assets Q2 2024 · Jun 30, 2024 $5.67M
Current Assets Q2 2024 · Dec 31, 2023 $5.38M
Total Assets Q2 2024 · Jun 30, 2024 $5.67M
Total Assets Q2 2024 · Dec 31, 2023 $5.38M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.18
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.51
Eps Diluted Q2 2024 · Jun 30, 2023 −$1.05
Eps Diluted Q2 2024 · Jun 30, 2023 −$1.97
Eps Basic Q2 2024 · Jun 30, 2024 −$0.18
Eps Basic Q2 2024 · Jun 30, 2024 −$0.51
Eps Basic Q2 2024 · Jun 30, 2023 −$1.05
Eps Basic Q2 2024 · Jun 30, 2023 −$1.97
Sga Expense Q2 2024 · Jun 30, 2024 $2.23M
Sga Expense Q2 2024 · Jun 30, 2024 $4.69M
Sga Expense Q2 2024 · Jun 30, 2023 $2.28M
Sga Expense Q2 2024 · Jun 30, 2023 $4.57M
Rd Expense Q2 2024 · Jun 30, 2024 $4.48M
Rd Expense Q2 2024 · Jun 30, 2024 $12.98M
Rd Expense Q2 2024 · Jun 30, 2023 $13.95M
Rd Expense Q2 2024 · Jun 30, 2023 $29.77M
Net Income Q2 2024 · Jun 30, 2024 −$6.67M
Net Income Q2 2024 · Jun 30, 2024 −$17.62M
Net Income Q2 2024 · Jun 30, 2023 −$16.52M
Net Income Q2 2024 · Jun 30, 2023 −$27M
Operating Income Q2 2024 · Jun 30, 2024 −$6.67M
Operating Income Q2 2024 · Jun 30, 2024 −$17.62M
Operating Income Q2 2024 · Jun 30, 2023 −$16.2M
Operating Income Q2 2024 · Jun 30, 2023 −$34.28M
Revenue Q2 2024 · Jun 30, 2024 $41K
Revenue Q2 2024 · Jun 30, 2024 $41K
Revenue Q2 2024 · Jun 30, 2023 $31K
Revenue Q2 2024 · Jun 30, 2023 $66K